利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

304 条记录 (耗时 0.037 秒)

    Composition for nucleic-acid transfection
    4.
    发明授权
    Composition for nucleic-acid transfection 有权
    用于核酸转染的组合物

    公开(公告)号：US08227248B2

    公开(公告)日：2012-07-24

    申请号：US12306620

    申请日：2007-06-29

    申请人： Hiroshi Kikuchi ,  Hideo Kobayashi ,  Kouichi Hashimoto ,  Ayako Iijima ,  Daigo Asano

    发明人： Hiroshi Kikuchi ,  Hideo Kobayashi ,  Kouichi Hashimoto ,  Ayako Iijima ,  Daigo Asano

    IPC分类号： C12N15/88

    CPC分类号： C12N15/88 ,  A61K9/1272

    摘要： To provide a nucleic-acid-transfecting composition which exhibits low cytotoxicity, which facilitates a nucleic acid transfection into cells, and which improves expression of the nucleic acid in the cells. The invention provides a composition for transfecting a nucleic acid into a cell, including a compound represented by the following formula (I) (wherein each of R1 and R2, which are identical to or different from each other, represents a saturated or unsaturated hydrocarbon group; R3 represents a C1-6 alkyl group or a C1-6 hydroxyalkyl group; m is an integer from 1 to 10; and X represents a halogen atom), and a phospholipid.

    摘要翻译： 提供显示低细胞毒性的核酸转染组合物，其有助于核酸转染入细胞，并且其改善核酸在细胞中的表达。 本发明提供一种用于将核酸转染入细胞的组合物，包括由下式（I）表示的化合物（其中R 1和R 2各自彼此相同或不同，表示饱和或不饱和的烃基 R 3表示C 1-6烷基或C 1-6羟基烷基; m表示1〜10的整数，X表示卤素原子）和磷脂。

    COMPOSITION FOR INTRODUCTION OF NUCLEIC ACID
    5.
    发明申请
    COMPOSITION FOR INTRODUCTION OF NUCLEIC ACID 审中-公开
    用于引入核酸的组合物

    公开(公告)号：US20090233366A1

    公开(公告)日：2009-09-17

    申请号：US12432577

    申请日：2009-04-29

    申请人： Hiroshi Kikuchi ,  Kouichi Hashimoto ,  Hideo Kobayashi ,  Ayako Iijima ,  Daigo Asano

    发明人： Hiroshi Kikuchi ,  Kouichi Hashimoto ,  Hideo Kobayashi ,  Ayako Iijima ,  Daigo Asano

    IPC分类号： C12N15/88 ,  C07K5/10 ,  C07K7/06 ,  C07K7/08

    CPC分类号： A61K9/127 ,  A61K48/0041

    摘要： Composition with weak cytotoxicity for introducing a nucleic acid, such as a short oligonucleotide or a gene, into a cell for expression of the gene in the cell. The composition includes a lipid and a compound represented by a formula (I): (R1)n-R2-R3  (I) wherein (R1)n represents a polyamino acid residue consisting of a total of n amino acid residues, which are identical to or different from one another, the n residues being selected from an arginine residue, a lysine residue, and a histidine residue, and n being an integer of from 4 to 16; R2 represents a single bond or an amino acid residue; and R3 represents a phospholipid residue with 1 or 2 identical or different unsaturated fatty acid residues having from 12 to 20 carbon atoms. The composition is administered or supplied to a cell together with a nucleic acid.

    摘要翻译： 用于将核酸如短寡核苷酸或基因导入用于在细胞中表达基因的细胞的细胞毒性弱的组合物。 组合物包括脂质和由式（I）表示的化合物：<？in-line-formula description =“In-line Formulas”end =“lead”？>（R1）n-R2-R3（I） 其中（R1）n表示由总共n个氨基酸残基组成的聚氨基酸残基，它们彼此相同或不同。 n残基选自精氨酸残基，赖氨酸残基和组氨酸残基，n为4〜16的整数， R2表示单键或氨基酸残基; R3表示具有1或2个相同或不同的具有12至20个碳原子的不饱和脂肪酸残基的磷脂残基。 组合物与核酸一起施用或提供给细胞。

    COMPOSITION FOR NUCLEIC-ACID TRANSFECTION
    6.
    发明申请
    COMPOSITION FOR NUCLEIC-ACID TRANSFECTION 有权
    用于核酸转运的组合物

    公开(公告)号：US20090239222A1

    公开(公告)日：2009-09-24

    申请号：US12306620

    申请日：2007-06-29

    申请人： Hiroshi Kikuchi ,  Hideo Kobayashi ,  Kouichi Hashimoto ,  Ayako Iijima ,  Daigo Asano

    发明人： Hiroshi Kikuchi ,  Hideo Kobayashi ,  Kouichi Hashimoto ,  Ayako Iijima ,  Daigo Asano

    IPC分类号： C12Q1/68 ,  C07C233/00

    CPC分类号： C12N15/88 ,  A61K9/1272

    摘要： To provide a nucleic-acid-transfecting composition which exhibits low cytotoxicity, which facilitates a nucleic acid transfection into cells, and which improves expression of the nucleic acid in the cells.The invention provides a composition for transfecting a nucleic acid into a cell, including a compound represented by the following formula (I) (wherein each of R1 and R2, which are identical to or different from each other, represents a saturated or unsaturated hydrocarbon group; R3 represents a C1-6 alkyl group or a C1-6 hydroxyalkyl group; m is an integer from 1 to 10; and X represents a halogen atom), and a phospholipid.

    摘要翻译： 提供显示低细胞毒性的核酸转染组合物，其有助于核酸转染入细胞，并且其改善核酸在细胞中的表达。 本发明提供一种用于将核酸转染入细胞的组合物，包括由下式（I）表示的化合物（其中R 1和R 2各自彼此相同或不同，表示饱和或不饱和的烃基 R 3表示C 1-6烷基或C 1-6羟基烷基; m表示1〜10的整数，X表示卤素原子）和磷脂。

    Quinolone-containing medicinal composition
    10.
    发明申请
    Quinolone-containing medicinal composition 审中-公开
    含喹诺酮的药物组合物

    公开(公告)号：US20090117205A1

    公开(公告)日：2009-05-07

    申请号：US11631395

    申请日：2005-07-01

    申请人： Emi Yano ,  Hideo Kobayashi ,  Hiroshi Kikuchi ,  Yuri Yamaguchi ,  Toshimasa Jindo ,  Norihiro Nishimoto

    发明人： Emi Yano ,  Hideo Kobayashi ,  Hiroshi Kikuchi ,  Yuri Yamaguchi ,  Toshimasa Jindo ,  Norihiro Nishimoto

    IPC分类号： A61K31/4709 ,  A61K33/14

    CPC分类号： A61K31/4709 ,  A61K9/0019 ,  A61K33/06 ,  A61K33/14 ,  A61K47/02 ,  A61K2300/00

    摘要： The present invention relates to a pharmaceutical solution comprising the following components (A) and (B):(A) a compound represented by the following formula (1): or a salt thereof, or a hydrate thereof; and(B) a multivalent metal compound, whereinmolar ratio of the component (B) to component (A) (the multivalent compound/component (B)) is 0.01 to 0.7. A pharmaceutical solution adapted for intravascular administration containing the quinolone compound at a therapeutically sufficient amount is provided, and this solution exhibits reduced toxicity even when the multivalent metal compound were incorporated at a reduced amount.

    摘要翻译： 本发明涉及包含以下组分（A）和（B）的药物溶液：（A）由下式（1）表示的化合物或其盐或其水合物： 和（B）成分（B）与成分（A）（多价化合物/成分（B））的摩尔比为0.01〜0.7的多价金属化合物。 提供了适于含有治疗上足够量的喹诺酮化合物的血管内施用的药物溶液，即使以降低的量掺入多价金属化合物，该溶液也显示出降低的毒性。